一个MYH9综合征家系2例耳聋患者临床特征及耳聋基因检测分析

陈印宜; 张应爱; 高鑫; 陈美; 王顺兰; 张淑芳

doi:10.16016/j.1000-5404.201812098

您当前的位置：

首页 >

文章列表页 >

一个MYH9综合征家系2例耳聋患者临床特征及耳聋基因检测分析

临床医学 | 更新时间：2026-01-09

- 一个MYH9综合征家系2例耳聋患者临床特征及耳聋基因检测分析
- Clinical features and analysis of deafness genes in 2 patients from a Chinese family with MYH9 disorder
- 第三军医大学学报 2019年41卷第11期页码：1083-1089
- 作者机构：
  
  570208 海口，中南大学湘雅医学院附属海口医院中心实验室
- 作者简介：
  
  [张淑芳，E-mail：haikouyiyuan@126.comZHANG Shufang, E-mail:haikouyiyuan@126.com
- 基金信息：
  
  海南省重大科技计划项目(ZDKJ2017007);海南省卫生计生行业科研项目(18A200137)
- DOI：10.16016/j.1000-5404.201812098
  中图分类号： R394.5;R596.1;R764.43
- 收稿：2018-12-12，
  
  修回：2019-03-09，
  
  纸质出版：2019-06-15
- 稿件说明：
移动端阅览
陈印宜, 张应爱, 高鑫, 等. 一个MYH9综合征家系2例耳聋患者临床特征及耳聋基因检测分析[J]. 第三军医大学学报, 2019,41(11):1083-1089.

Yinyi CHEN, Ying'ai ZHANG, Xin GAO, et al. Clinical features and analysis of deafness genes in 2 patients from a Chinese family with MYH9 disorder[J]. Journal of Third Military Medical University, 2019, 41(11): 1083-1089.
陈印宜, 张应爱, 高鑫, 等. 一个MYH9综合征家系2例耳聋患者临床特征及耳聋基因检测分析[J]. 第三军医大学学报, 2019,41(11):1083-1089. DOI： 10.16016/j.1000-5404.201812098.

Yinyi CHEN, Ying'ai ZHANG, Xin GAO, et al. Clinical features and analysis of deafness genes in 2 patients from a Chinese family with MYH9 disorder[J]. Journal of Third Military Medical University, 2019, 41(11): 1083-1089. DOI： 10.16016/j.1000-5404.201812098.

摘要

目的

分析一个MYH9综合征家系中2例耳聋患者的表型特征，进行候选耳聋基因的突变筛查，明确该家系耳聋表型的基因突变位点。

方法

对家系进行详细的病史问诊及体格检查、血常规及生化检查、听力学检测、外周血涂片瑞-吉染色及MYH9蛋白质免疫荧光检测；抽提2例患者外周血基因组DNA，使用全外显子组测序技术对包括所有已知的100多个耳聋相关基因进行筛查并对可疑突变进行Sanger测序验证。

结果

该家系所有患者有巨大血小板、血小板减少和中性粒细胞包涵体三联征，系谱分析符合常染色体显性遗传特征。本研究2例耳聋患者还伴有贫血、高脂血症和转氨酶升高；耳聋表现为语后性、迟发型和渐进性听力下降，以中高频听力损失为主的感音神经性耳聋。全外显子组测序技术检测到

MYH9

基因致病突变位点：c.G4546C:p.V1516L，未发现其他已知遗传性耳聋基因的致病突变。

结论

该家系2例患者的耳聋表型可能与

MYH9

致病突变p.V1516L相关。

Abstract

Objective

To investigate the clinical features of 2 deafness patients from a family with MYH9 disorder

and search the candidate genes related to deafness for mutation sites in this family.

Methods

Their detailed medical histories were surveyed. Physical examination

routine blood test

biochemical test

audiological test

and Wright-Giemsa staining and immunofluorescence assay of MYH9 protein in the peripheral blood smears were performed. Genomic DNA was extracted from the peripheral blood samples of 2 patients. More than 100 known genes associated with deafness were sequenced by whole exome sequencing

and the results were confirmed by Sanger sequencing.

Results

All affected members in this family had the typical triad of giant platelets

thrombocytopenia and neutrophil inclusion bodies

and the pedigree analysis revealed autosomal dominant inheritance. In this study

the 2 deaf patients also suffered from anemia

hyperlipidemia and elevated levels of transaminase. The features of their deafness were postlingual deafness

late-onset and progressive hearing loss

and medium and high frequency dominant sensorineural hearing loss. Whole exome sequencing indicated that the pathogenic mutation site of

MYH9

gene was c.G4546C:p.V1516L

and no other pathogenic mutations of known genes involved in deafness were found.

Conclusion

The deafness phenotype of the 2 patients in this family may be related to the

MYH9

pathogenic mutation p.V1516L.

关键词

Keywords

references

KELLEY M J, JAWIEN W, ORTEL T L, et al . Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly[J ] . Nat Genet, 2000, 26(1): 106-108. DOI:10.1038/79069.

KUNISHIMA S, KOJIMA T, MATSUSHITA T, et al . Mutations in the NMMHC-A gene cause autosomal dom inant macrothrombocytopenia with leukocyte inclusions (May-Hegglin anomaly/Sebastian syndrome)[J ] . Blood, 2001, 97(4): 1147-1149. DOI:10.5050/KSNVE.2010.20.12.1153.

石理华, 刘乾, 刘沙, 等.我国部分汉族人群MYH9多态性与终末期肾病的关联研究[J].中国免疫学杂志, 2016, 32(1):79-82, 89.DOI:10.3969/j.issn.1000-484X.2016.01.017.

SHI L H, LIU Q, LIU S, et al . Association of MYH9 SNPs with end-stage renal disease in Chinese Han population[J ] . Chin J Immunol, 2016, 32(1): 79-82, 89. DOI:10.3969/j.issn.1000-484X.2016.01.017.

PECCI A, BⅡNO G, FIERRO T, et al . Alteration of liver enzymes is a feature of the MYH9-related disease syndrome[J ] . PLoS ONE, 2012, 7(4): e35986. DOI:10.1371/journal.pone.0035986.

PECCI A, MA X F, SAVOIA A, et al . MYH9: Structure, functions and role of non-muscle myosin ⅡA in human disease[J ] . Gene, 2018, 664: 152-167. DOI:10.1016/j.gene.2018.04.048.

ZHANG S F, ZHOU X Y, LIU S N, et al . MYH9-related disease: description of a large Chinese pedigree and a survey of reported mutations[J ] . Acta Haematol, 2014, 132(2): 193-198. DOI:10.1159/000356681.

PECCI A, VERVER E J, SCHLEGEL N, et al . Cochlear implantation is safe and effective in patients with MYH9-related disease[J ] . Orphanet J Rare Dis, 2014, 9: 100. DOI:10.1186/1750-1172-9-100.

CANZI P, PECCI A, MANFRIN M, et al . Severe to profound deafness may be associated with MYH9-related disease: report of 4 patients[J ] . Acta Otorhinolaryngol Ital, 2016, 36(5): 415-420. DOI:10.14639/0392-100X-702.

VERVER E J, TOPSAKAL V, KUNST H P, et al . Nonmuscle myosin heavy chain ⅡA mutation predicts severity and progression of sensorineural hearing loss in patients with MYH9-related disease[J ] . Ear Hear, 2016, 37(1): 112-120. DOI:10.1097/AUD.0000000000000198.

PECCI A, KLERSY C, GRESELE P, et al . MYH9-related disease: A novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations[J ] . Hum Mutat, 2014, 35(2): 236-247. DOI:10.1002/humu.22476.

VERVER E, PECCI A, DE ROCCO D, et al . R705H mutation of MYH9 is associated with MYH9-related disease and not only with non-syndromic deafness DFNA17[J ] . Clin Genet, 2015, 88(1):85-89. DOI:10.1111/cge.12438.

WASANO K, MATSUNAGA T, OGAWA K, et al . Late onset and high-frequency dominant hearing loss in a family with MYH9 disorder[J ] . Eur Arch Otorhinolaryngol, 2016, 273(11):3547-3552. DOI:10.1007/s00405-016-3954-0.

WEI Q J, ZHU H M, QIAN X L, et al . Targeted genomic capture and massively parallel sequencing to identify novel variants causing Chinese hereditary hearing loss[J ] . J Transl Med, 2014, 12:311.DOI:10.1186/s12967-014-0311-1.

WANG C C, YUAN H J. Application and progress of high-throughput sequencing technologies in the research of hereditary hearing loss[J]. Hereditas, 2017, 39(3):208-219. DOI:10.16288/j.yczz.16-376.

EBRAHIM S, FUJITA T, MILLIS B A, et al . NMⅡ forms a contractile transcellular sarcomeric network to regulate apical cell junctions and tissue geometry[J ] . Curr Biol, 2013, 23(8):731-736. DOI:10.1016/j.cub.2013.03.039.

WU C C, LIN Y H, LU Y C, et al . Application of massively parallel sequencing to genetic diagnosis in multiplex families with idiopathic sensorineural hearing impairment[J ] . PLoS ONE, 2013, 8(2):e57369. DOI:10.1371/journal.pone.0057369.

DANTAS V G, LEZIROVITZ K, YAMAMOTO G L, et al . c.G2114A MYH9 mutation (DFNA17) causes non-syndromic autosomal dominant hearing loss in a Brazilian family[J ] . Genet Mol Biol, 2014, 37(4):616-621. DOI:10.1590/S1415-47572014005000025.

KECSKEMÉTI N, SZÖNYI M, GÁBORJÁN A, et al . Analysis of GJB2 mutations and the clinical manifestation in a large Hungarian cohort[J ] . Eur Arch Otorhinolaryngol, 2018, 275(10): 2441-2448. DOI:10.1007/s00405-018-5083-4.

XIA W J, LIU F, MA D. Research progress in pathogenic genes of hereditary non-syndromic mid-frequency deafness[J]. Front Med, 2016, 10(2): 137-142. DOI:10.1007/s11684-016-0449-8.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

脉冲噪声所致爆震性听力损失人员中耳聋基因的突变谱研究

重庆部分地区苯丙氨酸羟化酶缺乏症患儿基因突变分析

新型十万目六边形微腔芯片数字PCR对肺癌基因突变的绝对定量分析

儿童视网膜母细胞瘤的基因型及临床表型分析

305例髓系肿瘤的基因突变图谱比较分析